pI: 4.1623 |
Length (AA): 121 |
MW (Da): 14480 |
Paralog Number:
0
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | gametocyte, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite. | PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Female Gametocyte. | Otto TD Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 32 hs, Oocyst, Ring, Sporozoite. | Otto TD Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 16 hs, Male Gametocyte. | Otto TD Lasonder E |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_129128)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G61280 | phosphatidylinositol N-acetylglucosaminyltransferase subunit P |
Arabidopsis thaliana | AT2G39445 | phosphatidylinositol N-acetylglucosaminyltransferase, GPI19/PIG-P subunit |
Candida albicans | CaO19.3557 | similar to S. pombe SPAC22A12.13 |
Candida albicans | CaO19.11041 | similar to S. pombe SPAC22A12.13 |
Cryptosporidium hominis | Chro.20095 | NPD010 |
Cryptosporidium parvum | cgd2_840 | phosphatidylinositol N-acetylglucosaminyltransferase subunit PIG-P, involved in GPI anchor biosynthesis, multitransmembrane doma |
Dictyostelium discoideum | DDB_G0272006 | hypothetical protein |
Drosophila melanogaster | Dmel_CG14550 | CG14550 gene product from transcript CG14550-RA |
Entamoeba histolytica | EHI_126130 | hypothetical protein |
Homo sapiens | ENSG00000185808 | phosphatidylinositol glycan anchor biosynthesis, class P |
Leishmania braziliensis | LbrM.35.5000 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_364980.1 | PIG-P, putative |
Leishmania infantum | LinJ.36.4980 | hypothetical protein, conserved |
Leishmania major | LmjF.36.4750 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.4750 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000022940 | phosphatidylinositol glycan anchor biosynthesis, class P |
Plasmodium berghei | PBANKA_0836100 | phosphatidylinositol N-acetylglucosaminyltransferase subunit P, putative |
Plasmodium falciparum | PF3D7_0935300 | phosphatidylinositol N-acetylglucosaminyltransferase subunit P, putative |
Plasmodium knowlesi | PKNH_0734000 | phosphatidylinositol N-acetylglucosaminyltransferase subunit P, putative |
Plasmodium vivax | PVX_086955 | phosphatidylinositol N-acetylglucosaminyltransferase subunit P, putative |
Saccharomyces cerevisiae | YDR437W | Gpi19p |
Schistosoma japonicum | Sjp_0045460 | IPR013717,PIG-P,domain-containing |
Schistosoma japonicum | Sjp_0205230 | ko:K03861 phosphatidylinositol glycan, class P, putative |
Schistosoma mansoni | Smp_163640 | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P |
Trypanosoma brucei gambiense | Tbg972.10.12340 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.10110 | PIG-P, putative |
Trypanosoma cruzi | TcCLB.508307.100 | PIG-P, putative |
Toxoplasma gondii | TGME49_207980 | PIG-P protein |
Theileria parva | TP04_0640 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.10110 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.10110 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.10110 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.10.10110 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YDR437W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0836100 | Plasmodium berghei | Essential | plasmo |
TGME49_207980 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.